Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

Trial Profile

Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2012

At a glance

  • Drugs Ciclosporin (Primary) ; Mycophenolate mofetil (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 13 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top